KEMPHARM INC (KMPH)
US4884452065 - Common Stock
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 70.06M | 112.35M | 4.21M | 3.22M | 18.41M | |||
| Marketable Securities | 5.83M | N/A | N/A | 0.00 | 3.26M | |||
| Receivables | 6.58M | 1.53M | 2.58M | 1.87M | 140.00K | |||
| Other Current Assets | 2.66M | 1.18M | 1.59M | 1.56M | 1.91M | |||
| Total Current Assets | 85.13M | 115.06M | 8.38M | 6.63M | 23.72M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.92M | 2.02M | 2.39M | 3.01M | 1.75M | |||
| Investments And Advances | 31.46M | 15.42M | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | 635.00K | 438.00K | 440.00K | 870.00K | 1.27M | |||
| Total Non-Current Assets | 34.42M | 17.89M | 2.83M | 3.88M | 3.03M | |||
| TOTAL ASSETS | 119.55M | 132.94M | 11.21M | 10.51M | 26.75M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 7.00K | 15.00K | 560.00K | 240.00K | 3.55M | |||
| Accrued Expenses | 474.00K | 2.88M | 5.80M | 280.00K | 4.63M | |||
| Accounts Payable | 4.28M | 516.00K | 1.17M | 4.91M | 3.72M | |||
| Other Current Liabilities | 3.67M | 821.00K | N/A | N/A | 120.00K | |||
| Total Current Liabilities | 8.43M | 4.23M | 7.54M | 5.43M | 12.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 12.80M | 6.00K | 68.07M | 77.51M | 78.50M | |||
| Other Non-Current Liabilities | 4.53M | 1.59M | 2.01M | 2.02M | 2.81M | |||
| Total Non-Current Liabilities | 17.33M | 1.59M | 70.08M | 79.53M | 81.31M | |||
| TOTAL LIABILITIES | 25.76M | 5.82M | 77.62M | 84.96M | 93.31M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -299.55M | -267.03M | -258.47M | -245.71M | -221.19M | |||
| Additional Paid In Capital | 400.68M | 396.96M | 192.06M | 171.25M | 154.62M | |||
| Common Shares | 3.00K | 4.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -7.54M | -2.81M | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 201.00K | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 34.50M | 35.01M | 4.54M | 2.27M | 1.65M | |||
| Tangible Book Value per Share | 2.72 | 3.63 | -14.63 | -32.80 | -40.35 | |||
| Total Shareholders' Equity | 93.79M | 127.12M | -66.41M | -74.46M | -66.57M | |||
| TOTAL LIABILITIES AND EQUITY | 119.55M | 132.94M | 11.21M | 10.51M | 26.75M | |||
| Statistics | ||||||||
| Debt/Equity | 0.14 | 0.00 | -1.02 | -1.04 | -1.18 | |||
| Current Ratio | 10.10 | 27.20 | 1.11 | 1.22 | 1.98 | |||
| Return On Assets (ROA) | -29.46% | -47.31% | -113.83% | -233.30% | -211.10% | |||
| Return On Equity (ROE) | -37.56% | -49.48% | N/A | N/A | N/A | |||
| Return On Invested Capital (ROIC) | N/A | 4.74% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 37.31% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | 37.31% | N/A | N/A | N/A | |||
All data in USD